JP2022553268A5 - - Google Patents
Info
- Publication number
- JP2022553268A5 JP2022553268A5 JP2022523275A JP2022523275A JP2022553268A5 JP 2022553268 A5 JP2022553268 A5 JP 2022553268A5 JP 2022523275 A JP2022523275 A JP 2022523275A JP 2022523275 A JP2022523275 A JP 2022523275A JP 2022553268 A5 JP2022553268 A5 JP 2022553268A5
- Authority
- JP
- Japan
- Prior art keywords
- alkali metal
- metal salt
- copolymer
- methyl methacrylate
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024153951A JP7771316B2 (ja) | 2019-10-18 | 2024-09-06 | 組成物 |
| JP2025186783A JP2026027357A (ja) | 2019-10-18 | 2025-11-05 | 組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201915094A GB201915094D0 (en) | 2019-10-18 | 2019-10-18 | New formulations |
| GB1915094.5 | 2019-10-18 | ||
| PCT/GB2020/052618 WO2021074646A1 (en) | 2019-10-18 | 2020-10-16 | New formulations |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024153951A Division JP7771316B2 (ja) | 2019-10-18 | 2024-09-06 | 組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022553268A JP2022553268A (ja) | 2022-12-22 |
| JP2022553268A5 true JP2022553268A5 (enExample) | 2023-10-24 |
| JP7554263B2 JP7554263B2 (ja) | 2024-09-19 |
Family
ID=68728312
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523275A Active JP7554263B2 (ja) | 2019-10-18 | 2020-10-16 | アルカリ金属塩、薬学的製剤、アルカリ金属塩の使用、及びプロセス |
| JP2024153951A Active JP7771316B2 (ja) | 2019-10-18 | 2024-09-06 | 組成物 |
| JP2025186783A Pending JP2026027357A (ja) | 2019-10-18 | 2025-11-05 | 組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024153951A Active JP7771316B2 (ja) | 2019-10-18 | 2024-09-06 | 組成物 |
| JP2025186783A Pending JP2026027357A (ja) | 2019-10-18 | 2025-11-05 | 組成物 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20230096218A1 (enExample) |
| EP (2) | EP4045038B1 (enExample) |
| JP (3) | JP7554263B2 (enExample) |
| KR (1) | KR20220084379A (enExample) |
| CN (2) | CN119112886A (enExample) |
| AU (1) | AU2020366142A1 (enExample) |
| CA (1) | CA3154915A1 (enExample) |
| DK (1) | DK4045038T3 (enExample) |
| ES (1) | ES2977279T3 (enExample) |
| FI (1) | FI4045038T3 (enExample) |
| GB (1) | GB201915094D0 (enExample) |
| HU (1) | HUE066075T2 (enExample) |
| MX (2) | MX2022004615A (enExample) |
| PL (1) | PL4045038T3 (enExample) |
| PT (1) | PT4045038T (enExample) |
| WO (1) | WO2021074646A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11691954B2 (en) | 2019-10-18 | 2023-07-04 | Betagenon Ab | Formulations |
| GB202100352D0 (en) * | 2021-01-12 | 2021-02-24 | Balticgruppen Bio Ab | New methods |
| WO2025017193A1 (en) * | 2023-07-20 | 2025-01-23 | Betagenon Ab | Methods of treating cardiomyopathy induced by metabolic inflexibility |
| WO2025017194A1 (en) * | 2023-07-20 | 2025-01-23 | Betagenon Ab | Methods for regulating blood glucose levels using a dual ampk activator and mitochondrial uncoupler |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2166328B1 (es) | 2000-05-11 | 2003-09-16 | Consejo Superior Investigacion | Inhibidores heterociclicos del enzima gsk 3 utiles en el tratamiento de procesos neurodegenerativos e hiperproliferativos |
| WO2006045581A1 (en) | 2004-10-21 | 2006-05-04 | Neuropharma, S.A. | The use of 1, 2, 4-thiadiazolidine-3, 5-diones as ppar activators |
| UA94724C2 (en) * | 2005-12-08 | 2011-06-10 | Новартис Аг | Thiadiazolidinone derivatives as antidiabetic agents |
| JP5982281B2 (ja) | 2009-07-08 | 2016-08-31 | バルティック バイオ アーベー | 医薬として有用な化合物 |
| WO2013108026A1 (en) * | 2012-01-17 | 2013-07-25 | Baltic Bio Ab | Thiadiazolone derivatives useful in the treatment of diabetes |
| AU2018448511B2 (en) * | 2018-11-05 | 2025-07-03 | Betagenon Ab | Methods of treating diabetes in severe insulin-resistant diabetic subjects |
-
2019
- 2019-10-18 GB GB201915094A patent/GB201915094D0/en not_active Ceased
-
2020
- 2020-10-16 US US17/769,666 patent/US20230096218A1/en not_active Abandoned
- 2020-10-16 DK DK20799795.8T patent/DK4045038T3/da active
- 2020-10-16 WO PCT/GB2020/052618 patent/WO2021074646A1/en not_active Ceased
- 2020-10-16 JP JP2022523275A patent/JP7554263B2/ja active Active
- 2020-10-16 CN CN202411247521.7A patent/CN119112886A/zh active Pending
- 2020-10-16 FI FIEP20799795.8T patent/FI4045038T3/fi active
- 2020-10-16 ES ES20799795T patent/ES2977279T3/es active Active
- 2020-10-16 PL PL20799795.8T patent/PL4045038T3/pl unknown
- 2020-10-16 CA CA3154915A patent/CA3154915A1/en active Pending
- 2020-10-16 CN CN202080072849.3A patent/CN114630824B/zh active Active
- 2020-10-16 AU AU2020366142A patent/AU2020366142A1/en active Pending
- 2020-10-16 EP EP20799795.8A patent/EP4045038B1/en active Active
- 2020-10-16 EP EP23200594.2A patent/EP4316470B1/en active Active
- 2020-10-16 KR KR1020227016816A patent/KR20220084379A/ko active Pending
- 2020-10-16 PT PT207997958T patent/PT4045038T/pt unknown
- 2020-10-16 MX MX2022004615A patent/MX2022004615A/es unknown
- 2020-10-16 HU HUE20799795A patent/HUE066075T2/hu unknown
-
2022
- 2022-04-18 MX MX2025003950A patent/MX2025003950A/es unknown
-
2024
- 2024-09-06 JP JP2024153951A patent/JP7771316B2/ja active Active
-
2025
- 2025-11-05 JP JP2025186783A patent/JP2026027357A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022553268A5 (enExample) | ||
| JP3015105B2 (ja) | 粉末被覆経口投与剤形 | |
| CA2251430C (en) | Omeprazole formulation | |
| JP5285913B2 (ja) | 経口投与できる固体の放出改変型医薬投与形 | |
| US10172794B2 (en) | Controlled release dosage form for once daily administration of dimethyl fumarate | |
| CN109044981B (zh) | 一种普瑞巴林胃漂浮型缓释片及其制备方法 | |
| JP2001524131A (ja) | 安定な経口医薬品剤形 | |
| JP2011093938A (ja) | 副作用が低減されたトラネキサム酸製剤 | |
| FI4045038T3 (fi) | 4-kloori-n-[2-[(4-kloorifenyyli)metyyli]-3-okso-1,2,4-tiadiatsol-5-yl]bentsamidin uudet formulaatiot | |
| WO2008064202A2 (en) | Modified-release formulations of calcium receptor-active compounds | |
| RU2744576C2 (ru) | Пероральные фармацевтические композиции месалазина | |
| CN1317959A (zh) | 搅动非依赖性多元缓释药物制剂及其制备方法 | |
| US8568785B2 (en) | Process for producing spherical base granule comprising easily water-soluble drug | |
| JP7064683B2 (ja) | 腸溶層破損防止用組成物 | |
| US20090004284A1 (en) | Controlled release tamsulosin hydrochloride formulation | |
| WO2014030204A1 (ja) | 薬物含有中空粒子 | |
| CN1744889A (zh) | 坦洛新的控释药物组合物 | |
| CN103585112A (zh) | 一种坦洛新肠溶缓释微丸及其制备方法 | |
| JP2008519070A5 (enExample) | ||
| KR20090122344A (ko) | 실로스타졸을 함유하는 제어방출 제제 및 이의 제조방법 | |
| CN109152772B (zh) | 烟酰胺的口服药物组合物 | |
| US10918630B2 (en) | Delayed release pharmaceutical composition of pantoprazole and process for formulation thereof | |
| CN108012526A (zh) | 具有改进的生物利用度的含普仑司特固体制剂的组合物及其制备方法 | |
| JP6856326B2 (ja) | 腸放出粒子組成物 | |
| JP2008519069A5 (enExample) |